A U.S. jury on Wednesday awarded $81 million to a man who claimed his use of Bayer's glyphosate-based weed killer Roundup caused his cancer, in the latest legal setback for the company facing thousands of similar lawsuits.
The jury in San Francisco federal court said the company was liable for plaintiff Edwin Hardeman's non-Hodgkin's lymphoma.
It awarded $5.9 million in compensatory and $75 million in punitive damages to Hardeman after finding that Roundup was defectively designed, that Monsanto failed to warn of the herbicide's cancer risk and that the company acted negligently.The company denies the allegations, saying decades of studies by independent scientists have shown glyphosate and Roundup to be safe for human use.
The trial is only the second of more than 11,200 Roundup lawsuits set to go to trial in the United States. Previous litigation setbacks and a prior jury verdict against the company have sent Bayer shares plunging. The verdict comes roughly a week after the same jury on March 19 found Roundup to have been a"substantial factor" in causing Hardeman's cancer, allowing the trial to proceed into a second phase to determine liability and damages. Bayer shares fell more than 12 percent after last week's jury finding.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
U.S. jury says Bayer must pay $81 million to man in Roundup cancer trialJury says Bayer, which bought Monsanto last year, must pay $81 million to a man who claimed the company's Roundup weed killer caused his non-Hodgkin's lymphoma
Read more »
U.S. jury says Bayer must pay $81 million to man in Roundup cancer trialA U.S. jury on Wednesday awarded $81 million to a man who claimed his use of Bayer AG's glyphosate-based weed killer Roundup caused his cancer, in the latest legal setback for the company facing thousands of similar lawsuits. The jury in San Francisco federal court said the company was liable for
Read more »
Ten more Brazilian states' soy growers join Bayer patent disputeSoy producer associations in 10 Brazilian states have filed a legal petition to ...
Read more »
Bayer CEO says his team retains backing of supervisory board: reportBayer's management retains the backing of its supervisory board, its chief ...
Read more »
Bayer, J&J settle blood thinner Xarelto litigation for $775 millionBayer AG and Johnson & Johnson have agreed to settle more than 25,000 U.S. lawsuits over their blockbuster blood thinner Xarelto for a total of $775 million, court documents on Monday showed.
Read more »
Bayer, J&J settle U.S. Xarelto litigation for $775 millionBayer AG and Johnson & Johnson have agreed to settle more than 25,000 U.S. lawsu...
Read more »
Jury finding upends Bayer's Roundup defense strategy: expertsBayer AG had hoped a new trial strategy focusing jurors on scientific evidence c...
Read more »
U.S. jury to determine liability, damages in Roundup cancer trialA lawyer for a man who said his cancer was caused by Bayer AG's glyphosate-...
Read more »